# Gentherm Inc: Form 10-Q for the period ended Sep 30, 2012

- Company: [Gentherm Inc](/companies/thrm.md) (CIK 903129)
- Form: 10-Q
- Filed: 2012-11-05
- Accepted by EDGAR: Nov 5, 2012, 15:43 ET
- Period: 2012-09-30
- Accession: 0001193125-12-450815
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/903129/000119312512450815/d398788d10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/903129/000119312512450815/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2012-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2012-07-01 to 2012-09-30 | $141.1m | us-gaap:Revenues |
| Revenue | 9 months, 2012-01-01 to 2012-09-30 | $406.7m | us-gaap:Revenues |
| Cost of revenue | 3 months, 2012-07-01 to 2012-09-30 | $104.3m | us-gaap:CostOfGoodsSold |
| Cost of revenue | 9 months, 2012-01-01 to 2012-09-30 | $303.3m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months, 2012-07-01 to 2012-09-30 | $36.8m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2012-01-01 to 2012-09-30 | $103.5m | us-gaap:GrossProfit |
| Research and development | 3 months, 2012-07-01 to 2012-09-30 | $10.7m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2012-01-01 to 2012-09-30 | $31.5m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2012-07-01 to 2012-09-30 | $16.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2012-01-01 to 2012-09-30 | $46.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2012-07-01 to 2012-09-30 | $10.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2012-01-01 to 2012-09-30 | $27.8m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2012-07-01 to 2012-09-30 | $2.4m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2012-01-01 to 2012-09-30 | $7.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2012-07-01 to 2012-09-30 | $4.1m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2012-01-01 to 2012-09-30 | $14.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2012-07-01 to 2012-09-30 | $0.09 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2012-01-01 to 2012-09-30 | $0.31 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2012-07-01 to 2012-09-30 | $0.09 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2012-01-01 to 2012-09-30 | $0.32 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2012-07-01 to 2012-09-30 | 30,003,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2012-01-01 to 2012-09-30 | 28,676,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2012-01-01 to 2012-09-30 | $29.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2012-01-01 to 2012-09-30 | $15.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2012-09-30 | $72.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2012-09-30 | $252.0m | us-gaap:AssetsCurrent |
| Total assets | at 2012-09-30 | $458.5m | us-gaap:Assets |
| Current liabilities | at 2012-09-30 | $133.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2012-09-30 | $216.9m | us-gaap:Liabilities |
| Shareholders' equity | at 2012-09-30 | $161.3m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 29,104 characters.

### General

Gentherm Incorporated (formally known as Amerigon Incorporated until September 5, 2012) designs, develops, manufactures and markets proprietary technology electronic components and systems for sale to car and truck original equipment manufacturers (“OEMs”). One of the Gentherm’s primary automotive seat comfort products is the Climate Control Seat™ (“CCS™”), which provides year-round comfort by providing both heating and cooling to seat occupants. During the second quarter of 2011, Gentherm acquired a majority interest in W.E.T. Automotive Systems AG (“W.E.T.”), a developer, manufacturer and distributor of heating and cooling systems, interior equipment, electronics and accessories used in automobile seats and other automotive and electronic applications in the automotive industry. The activities of W.E.T. represent a significant portion of the Company’s consolidated assets, liabilities, revenues and expenses. The term “historical Gentherm” used herein excludes W.E.T.

#### Third Quarter 2012 Compared with Third Quarter 2011

The following table presents select operations data for the period as reported, amounts for W.E.T. operations and amounts for Gentherm less the W.E.T. amounts representing the historical portion of Gentherm. These historical Gentherm financial results, which are non-GAAP measures, are provided to help shareholders understand Gentherm’s results of operations in light of the 2011 acquisition of W.E.T. These non-GAAP financial measures should be viewed in addition to, and not as an alternative for, Gentherm’s reported results prepared in accordance with GAAP.

*(In Thousands)*

|  | Three month period ended September 30, 2012 As Reported | Less: W.E.T. | Historical Gentherm |
| --- | ---: | ---: | ---: |
| Product revenues | $141,058 | $107,092 | $33,966 |
| Cost of sales | 104,258 | 80,203 | 24,055 |
| Gross margin | 36,800 | 26,889 | 9,911 |
| Gross margin percent | 26.1% | 25.1% | 29.2% |
| Operating expenses: |  |  |  |
| Net research and development expenses | 10,046 | 7,988 | 2,058 |
| Selling, general and administrative expenses (1) | 16,560 | 10,652 | 5,908 |
| Operating income | 10,194 | 8,249 | 1,945 |
| Earnings before income tax | 8,195 | 6,875 | 1,320 |

(1) During the Third Quarter 2012, historical Gentherm incurred approximately $600 in expenses related to the DPLTA and Sarbanes-Oxley compliance for W.E.T. within selling, general and administrative expenses. See the Liquidity and Capital Resources section of this report for additional information about the DPLTA.

*(In Thousands)*

|  | Three month period ended September 30, 2011 As Reported | Less: W.E.T. | Historical Gentherm |
| --- | ---: | ---: | ---: |
| Product revenues | $125,639 | $95,122 | $30,517 |
| Cost of sales | 94,795 | 72,584 | 22,211 |
| Gross margin | 30,844 | 22,538 | 8,306 |
| Gross margin percent | 24.5% | 23.7% | 27.2% |
| Operating expenses: |  |  |  |
| Net research and development expenses | 11,285 | 8,949 | 2,336 |
| Acquisition transaction expenses | 200 | 6 | 194 |
| Selling, general and administrative expenses | 13,545 | 9,838 | 3,707 |
| Operating income | 5,814 | 3,745 | 2,069 |
| Earnings before income tax | 2,492 | 1,030 | 1,462 |

*Product Revenues*. Product revenues for the three months ended September 30, 2012 (“Third Quarter 2012”) were $141,058,000 compared with product revenues of $125,639,000 for the three months ended September 30 2011 (“Third Quarter 2011”), an increase of $15,419,000, or 12%. Product revenues at W.E.T. for Third Quarter 2012 were $11,970,000 higher compared to Third Quarter 2011 driven by strong customer demand on existing vehicle programs, as well as new vehicle programs launched since September 30, 2011. W.E.T. revenues include the effect of the first historical Gentherm vehicle program to be produced in a W.E.T. facility totaling $6,534,000 for the Third Quarter 2012. Adding back the transferred program’s revenues in both periods, historical Gentherm’s product revenues would have increased $5,557,000, or 16%, reflecting new vehicle program launches since the end of the Third Quarter 2011 and expansion of certain programs into new geographic regions by our customers on existing vehicles. New program launches for CCS include the Ford Flex, Nissan Pathfinder, Infiniti JX, Hyundai i40 and Kia K9 Cadenza. Certain existing vehicle programs had higher revenue during the period as a result of our customers expanding the availability of our product to additional geographic regions, including the Kia Optima which is now also offered in the China and North American markets. Partially offsetting higher product revenues during the Third Quarter 2012 is a decline related to the weakening of the Euro against the U.S. dollar which negatively impacted our Euro denominated revenues. Our Euro denominated product revenue for the Third Quarter 2012 was €31,855,000 and the average US Dollar/Euro exchange rate for the quarter was 1.2514. If the average exchange rate for the quarter had been equal to the average US Dollar/Euro rate for all of 2011 of 1.407, we would have reported incrementally higher revenue of approximately $5,000,000.

*Cost of Sales*. Cost of sales increased to $104,258,000 in the Third Quarter 2012 from $94,795,000 in the Third Quarter 2011. This increase of $9,463,000, or 10%, is due to increased sales volume offset by higher gross margin percentages. A favorable change in product mix and greater coverage of fixed costs at the higher volume levels increased historical gross profit percentage during the Third Quarter 2012 to approximately 26% compared with 25% during the Third Quarter 2011.

*Net Research and Development Expenses*. Net research and development expenses were $10,046,000 in the Third Quarter 2012 compared to $11,285,000 in the Third Quarter 2011, a decrease of $1,239,000, or 11%, driven by a weakening of the Euro against the Dollar. The average Euro-to-Dollar exchange rate for Third Quarter 2012 decreased approximately 11% to 1.2541 compared with the Third Quarter 2011 rate of 1.407. The decrease in historical Gentherm’s research and development expense is due to an increase in funding reimbursements from U.S. Department of Energy sponsored research and product development.

We classify development and prototype costs and related reimbursements as research and development. This is consistent with accounting standards applied in the automotive industry. Depreciation costs for tooling are included in cost of sales.

*Acquisition Transaction Expenses.* We incurred $200,000 in fees and expenses associated with the acquisition of W.E.T. during the Third Quarter 2011. The acquisition closed in the second quarter of 2011. We did not incur any acquisition transaction expenses during the Third Quarter 2012.

*Selling, General and Administrative Expenses*. Selling, general and administrative expenses increased to $16,560,000 in the Third Quarter 2012 from $13,545,000 in the Third Quarter 2011, an increase of $3,015,000, or 22%. Historical Gentherm’s Third Quarter 2012 selling, general and administrative included approximately $150,000 in legal expenses related to a Domination and Profit and Loss Transfer Agreement (“DPLTA”) for W.E.T. and approximately $450,000 in incremental audit and accounting expenses driven by Sarbanes-Oxley compliance implementation for W.E.T. Approximately $500,000 in one-time fees associated with an investigation of a potential acquisition were incurred, in total, by W.E.T. and historical Gentherm. Historical Gentherm paid non-cash commissions of approximately $350,000 to our newly created Yongsan Korea JV on Hyundai and Kia vehicle sales in August and September, which was eliminated in consolidation. The remaining increase in historical Gentherm’s selling, general and administrative expenses is due to higher general legal, audit and travel costs, as well as wages and benefits costs resulting from new employee hiring and merit increases. We anticipate incurring additional expenses in the fourth quarter related to the Sarbanes-Oxley project for W.E.T. as well as a significant drop in these expenses in the first quarter of 2013 and going forward. See the Liquidity and Capital Resources section of this report for additional information about the DPLTA.

*Income Tax Expense.* We recorded an income tax expense of $2,425,000 during the Third Quarter 2012 representing an effective tax rate of 30% on earnings before income tax of $8,195,000. This effective tax rate was lower than the US Federal rate of 34% primarily due to the impact of lower statutory rates for our subsidiaries operating in foreign jurisdictions. During the Third Quarter 2011, we recorded an income tax expense of $973,000 representing an effective tax rate of 39% on earnings before income tax of $2,492,000. We had lower statutory tax rates in jurisdictions in which we experienced losses before income tax and higher statutory rates in jurisdictions in which we had earnings before income tax. The effect of these resulted in an effective tax rate higher than the US Federal rate. Our effective tax rate was estimated based upon a forecast of our full year results not including the non-deductible acquisition transaction costs which were reflected separately as a discrete tax item during 2011.

#### Nine Months Ending September 30, 2012 Compared with Nine Months Ending September 30, 2011

The following table presents select operations data for the period as reported, amounts for W.E.T. operations and amounts for Gentherm less the W.E.T. amounts representing the historical portion of Gentherm. These historical Gentherm financial results, which are non-GAAP measures, are provided to help shareholders understand Gentherm’s results of operations in light of the 2011 acquisition of W.E.T. These non-GAAP financial measures should be viewed in addition to, and not as an alternative for, Gentherm’s reported results prepared in accordance with GAAP.

*(In Thousands)*

|  | Nine month period ended September 30, 2012 As Reported | Less: W.E.T. | Historical Gentherm |
| --- | ---: | ---: | ---: |
| Product revenues | $406,737 | $310,620 | $96,117 |
| Cost of sales | 303,275 | 234,362 | 68,913 |
| Gross margin | 103,462 | 76,258 | 27,204 |
| Gross margin percent | 25.4% | 24.6% | 28.3% |
| Operating expenses: |  |  |  |
| Net research and development expenses | 29,717 | 22,974 | 6,743 |
| Selling, general and administrative expenses (1) | 45,972 | 31,010 | 14,962 |
| Operating income | 27,773 | 22,274 | 5,499 |
| Earnings before income tax | 26,623 | 23,001 | 3,622 |

(1) During the nine month period ending September 30, 2012, historical Gentherm incurred approximately $1,690 in expenses related to the DPLTA and Sarbanes-Oxley compliance for W.E.T. within selling, general and administrative expenses. See the Liquidity and Capital Resources section of this report for additional information about the DPLTA.

*(In Thousands)*

|  | Nine month period ended September 30, 2011 As Reported | Less: W.E.T. | Historical Gentherm |
| --- | ---: | ---: | ---: |
| Product revenues | $238,572 | $140,300 | $98,272 |
| Cost of sales | 177,671 | 107,042 | 70,629 |
| Gross margin | 60,901 | 33,258 | 27,643 |
| Gross margin percent | 25.5% | 23.7% | 28.1% |
| Operating expenses: |  |  |  |
| Net research and development expenses | 18,340 | 11,054 | 7,286 |
| Acquisition transaction expenses | 5,380 | 713 | 4,667 |
| Selling, general and administrative expenses | 26,092 | 15,912 | 10,180 |
| Operating income | 11,089 | 5,579 | 5,510 |
| Earnings before income tax | 5,788 | (353) | 6,141 |

*Product Revenues*. Product revenues for the nine months ended September 30, 2012 (“YTD 2012”) were $406,737,000 compared with product revenues of $238,572,000 for the nine months ended September 30, 2011 (“YTD 2011”), an increase of $168,165,000, or 70%, reflecting a full nine months of W.E.T. revenues earned in YTD 2012 compared with four and a half months of W.E.T. revenues earned in YTD 2011. W.E.T. revenues include the effect of the first historical Gentherm vehicle program to be produced in a W.E.T. facility totaling $20,650,000 for YTD 2012. Adding back the transferred program’s revenues for both periods, historical Gentherm’s product revenues would have increased $14,069,000, or 14%, reflecting new vehicle program launches since the end of the Third Quarter 2011 and expansion of certain programs into new geographic regions by our customers on existing vehicles. New program launches for CCS include the Ford Flex, Nissan Pathfinder, Infiniti JX, Hyundai i40 and Kia K9 Cadenza. Certain existing vehicle programs had higher revenue during the period as a result of our customers expanding the availability of our product to additional geographic regions. These vehicles include the Kia Optima which is now also offered in the China and North American markets. Partially offsetting higher product revenues during YTD 2012 is a decline related to the weakening of the Euro against the U.S. dollar which negatively impacted our Euro denominated revenues. Our Euro denominated product revenue for the YTD 2012 was €95,483,000 and the average US Dollar/Euro exchange rate for YTD 2012 was 1.2824. If the average exchange rate for YTD 2012 been equal to the average US Dollar/Euro rate for all of 2011 of 1.3921, we would have reported incrementally higher revenue of approximately $10,500,000.

*Cost of Sales*. Cost of sales increased to $303,275,000 in YTD 2012 from $177,671,000 in YTD 2011. This increase of $125,604,000, or 71%, is due to a full nine months of W.E.T. cost of sales incurred in YTD 2012 compared with four and a half months of W.E.T. cost of sales incurred in YTD 2011, and by higher cost of sales for historical Gentherm, offset by slightly higher gross margin percentages. The $1,356,000, or 2%, decrease on cost of sales attributable to historical Gentherm is due to lower sales volumes on some of our foreign vehicle programs.

*Net Research and Development Expenses*. Net research and development expenses increased to $29,717,000 in YTD 2012 from $18,340,000 in YTD 2011, an increase of $11,377,000, or 62%, reflecting a full nine months of W.E.T. research and development expenses incurred in YTD2012 compared with four and a half months of W.E.T. expenses incurred in YTD 2011. The decrease in historical Gentherm is due to an increase in funding reimbursements from U.S. Department of Energy sponsored research and product development for YTD 2012 compared with YTD 2011.

We classify development and prototype costs and related reimbursements as research and development. This is consistent with accounting standards applied in the automotive industry. Depreciation costs for tooling are included in cost of sales.

*Acquisition Transaction Expenses.* We incurred $5,380,000 in fees and expenses associated with the acquisition of W.E.T. during YTD 2011. The acquisition closed in the second quarter of 2011. We did not incur any acquisition transaction expenses during YTD 2012.

*Selling, General and Administrative Expenses*. Selling, general and administrative expenses increased to $45,972,000 in YTD 2012 from $26,092,000 in YTD 2011. This $19,880,000, or 76%, increase is primarily due to a full nine months of W.E.T. expenses incurred in YTD 2012 compared with four and a half months of W.E.T. expenses in YTD 2011, and higher selling, general and administrative expenses at historical Gentherm. Historical Gentherm’s YTD 2012 selling, general and administrative expenses increased $4,782,000, or 47%, and included approximately $860,000 in expenses to pursue a DPLTA for W.E.T., and approximately $830,000 in expenses related to the Sarbanes-Oxley implementation for W.E.T., approximately $250,000 in one-time fees associated with an investigation of a potential merger, and approximately $350,000 in non-cash commissions paid to our newly created Yongsan Korea JV on Hyundai and Kia vehicle sales in August and September. The remaining increase in historical Gentherm’s selling, general and administrative expenses is due to higher general legal, audit and travel costs, as well as wages and benefits costs resulting from new employee hiring and merit increases. See the Liquidity and Capital Resources section of this report for additional information about the DPLTA.

*Income Tax Expense.* We recorded an income tax expense of $7,580,000 during YTD 2012 representing an effective tax rate of 28% on earnings before income tax of $26,623,000. This effective tax rate was lower than the US Federal rate of 34% primarily due to the impact of lower statutory rates for our subsidiaries operating in foreign jurisdictions. During YTD 2011, we recorded an income tax expense of $4,117,000 representing an effective tax rate of 71% on earnings before income tax of $5,788,000. We incurred acquisition transaction expenses of $5,380,000 which were not deductible and therefore our income tax expense for that same period did not reflect any related tax benefit. Our estimated effective tax rate for YTD 2011 was 37% before the effect of the non-deductible acquisition transaction expenses. Our effective tax rate was estimated based upon a forecast of our full year results not including the non-deductible acquisition transaction costs which were reflected separately as a discrete tax item during 2011.

### Liquidity and Capital Resources

The following table represents our cash and cash equivalents and short-term investments which are available for our business operations:

|  | September 30, 2012 | December 31, 2011 |
| --- | ---: | ---: |
| Cash and cash equivalents | $72,279,000 | $23,839,000 |

We manage our cash, cash equivalents in order to fund operating requirements and preserve liquidity to take advantage of future business opportunities. Cash and cash equivalents increased by $48,440,000 in YTD 2012. As of September 30, 2012, the Company had approximately $24,397,000 in cash and cash equivalent at foreign locations. If that cash and cash equivalents were needed for our operations in the U.S. in the future we would be required to accrue and pay U.S. taxes in order to repatriate these funds. Based on our current plans, we believe we have sufficient cash in the U.S. to fund our U.S. operations and our intent is to permanently reinvest these foreign amounts outside of the U.S.

Cash provided by operating activities during YTD 2012 was $29,373,000 and was attributable to net income of $19,043,000, net of non-cash adjustments. Non-cash adjustments included depreciation and amortization of $22,902,000, deferred tax provisions of $2,390,000, stock compensation of $911,000, gains on revaluation of financial derivatives of $1,064,000, excess tax benefit from equity awards and other items. Partially offsetting these was a net increase in net operating assets and liabilities of $12,905,000.

As of September 30, 2012, working capital was $119,019,000 as compared to $65,955,000 at December 31, 2011, an increase of $53,064,000, or 80%. This increase is primarily related to a public offering of 5,290,000 shares of common stock totaling $75,487,000, an increase in accounts receivable totaling $16,728,000, an increase in inventory totaling $4,250,000, an increase in prepaid and other assets of $7,264,000, partially offset by an increase in accounts payable of $4,622,000, an increase in accrued liabilities of $10,715,000 and by payments on our outstanding term notes and Series C Convertible Preferred Stock Total payments on outstanding term notes were $19,149,000, including mandatory repayments using proceeds from the sale of W.E.T. treasury shares, and total Series C Convertible Preferred Stock payments were $17,340,000. Working capital was also impacted by changes in currency exchange rates.

Cash used in investing activities was $26,559,000 during YTD 2012, reflecting purchases of property and equipment totaling $15,344,000, cash paid to acquire new derivative financial instruments of $7,787,000, cash paid to acquire new patents and patent application filings of $2,593,000 and cash loaned to an equity investment of $590,000. Purchases of property and equipment for the period are primarily related to expansion of production capacity, as well as replacement of existing equipment.

Cash provided by financing activities was $46,225,000 during YTD 2012, reflecting the public offering of common stock totaling $75,487,000, excess tax benefit from equity awards of $1,577,000, proceeds from exercises of Common Stock options of $733,000, borrowing of debt of $3,286,000 and $1,921,000 in proceeds from non-controlling interests related to the sale of W.E.T.’s outstanding treasury shares. These amounts were partially offset by aforementioned repayments on our outstanding term notes and Series C Convertible Preferred Stock totaling $19,149,000 and $17,340,000, respectively.

The Series C Convertible Preferred Stock is to be redeemed in nine equal quarterly installments beginning on September 1, 2011 and ending on September 1, 2013 (each, an “Amortization Date”) by paying cash, issuing shares of our Common Stock or any combination thereof for $10,000 per Preferred Share plus accumulated and unpaid dividends. Total Series C Convertible Preferred Stock installments made during the nine month period ended September 30, 2012 are as follows (in thousands, except share data):

|  | Installment Payments ($) | Cash ($) | Stock ($) | Stock (shares) |
| --- | ---: | ---: | ---: | ---: |
| Dividend | $2,810 | $1,780 | $1,030 | 80,169 |
| Principal | 23,340 | 15,560 | 7,780 | 600,309 |
| Total | $26,150 | $17,340 | $8,810 | 680,478 |

We intend to use a portion of the net proceeds from the public offering of common stock to pay our future obligations to holders of our Series C Preferred Stock. These future cash payment obligations, assuming such shares are not earlier converted into shares of common stock by the holders, are approximately as follows (in thousands):

|  | 2012 | 2013 | Total |
| --- | ---: | ---: | ---: |
| Dividend | $620 | $930 | $1,550 |
| Principal | 7,780 | 23,320 | 31,100 |
| Total | $8,400 | $24,250 | $32,650 |

On September 11, 2012, we borrowed ¥20,000, or $3,159, from Bank of China to fund a plant expansion project in China. The Bank of China loan is due in lump sum on September 10, 2013 with interest calculated at a fixed rate of 6.9%.

The Company has two outstanding credit agreements with a syndicate of banks led by Bank of America; the US Bank of America credit facility and the W.E.T. Bank of America credit facility. The US Bank of America credit facility consists of the US Term Note and Europe Term Note. These notes are subject to quarterly principal payments, with total principal amortization of 10% of the original principal amount in the first year and amortization of 12.5%, 15%, 17.5% and 20% of the original principal amount during years two, three, four and five, respectively with all remaining amounts owing under each term facility due and payable in full at the term loan maturity date. The W.E.T. Bank of America credit facility consists of the W.E.T. Term Note, which is subject to quarterly principal payments totaling 20% annually. Principal outstanding under both the US Bank of America credit facility and W.E.T. Bank of America credit facility will be due and payable in full on March 30, 2016. Interest is payable at least quarterly. The Company has the option to elect interest rates based on either a Eurocurrency (LIBOR or EUIBOR) rate (“Eurocurrency Rate Loans”) (0.20% – 0.60% at September 30, 2012) or a base rate (“Base Rate Loans”) plus a margin (“Applicable Rate”) which varies based on the Consolidated Leverage Ratio of the Company, as defined by the US and W.E.T. Bank of America credit agreements. The base rate is equal to the highest of the Federal Funds Rate (0.09% at September 30, 2012) plus 0.5%, Bank of America’s prime rate (3.25% at September 30, 2012), or a one month Eurocurrency rate plus 1.0%. The Applicable Rate for the current period is 2.5% for Eurocurrency Rate Loans and 2.0% for Base Rate Loans.

The Company must maintain certain financial ratios including a minimum Consolidated Fixed Charge Coverage Ratio and a maximum Leverage Ratio as defined by the Bank of America credit agreement.

As of September 30, 2012, we were in compliance with all terms as outlined in the credit agreement for each of the US Bank of America credit facility, the W.E.T. Bank of America credit facility and the Bank of China loan.

The following table summarizes the Company’s debt at September 30, 2012 and December 31, 2011.

|  | September 30,2012 Interest Rate | Principal Balance | December 31, 2011 Principal Balance |
| --- | ---: | ---: | ---: |
| US Term Note | 2.86% | $30,406 | $33,250 |
| Europe Term Note | 2.57% | 4,358 | 4,389 |
| W.E.T. Term Note | 2.79% | 20,602 | 34,903 |
| Bank of China | 6.90% | 3,165 | — |
| Capital Leases | 5.50% | 1,751 | 3,705 |
| Total debt |  | 60,282 | 76,247 |
| Current portion |  | (18,172) | (14,570) |
| Long-term debt, less current maturities |  | $42,110 | $61,677 |

On August 16, 2011, W.E.T. held its annual general assembly meeting during which the W.E.T. shareholders approved the adoption of a Domination and Profit and Loss Transfer Agreement (“DPLTA”). Under the terms of the DPLTA, when the DPLTA is registered, the minority shareholders of W.E.T. will be guaranteed a recurring, annual payment (the “Guaranteed Compensation”) of EUR 3.71 per share of W.E.T. held, subject to statutory taxes and deductions, resulting in a net payment of EUR 3.17 per share beginning in 2012; however, the minority shareholders of W.E.T. can elect to forego the Guaranteed Compensation and instead tender their shares to Gentherm Europe for a one-time cash payment of EUR 44.95 per share after the agreement is registered. If all minority shareholders of W.E.T. tendered their shares, the total payment obligation of Gentherm Europe would be approximately EUR 33,139,000.

A minority shareholder of W.E.T. filed an action in Germany to set aside the shareholder approval of the DPLTA based on alleged violations of German corporate law. As a result, the DPLTA has not yet been registered and will not go into effect until the minority shareholder action is resolved. See Part II, Item 1, Legal Proceedings, for further information concerning the aforementioned minority shareholder action.

In order to provide financing for the potential tender offer to the minority shareholders of W.E.T., the Company entered into an amendment to the US Bank of America credit facility, on October 28, 2011. The amendment provides for a $45,000,000 term loan facility for Gentherm Europe, which replaced Gentherm Europe’s then existing Europe Term Note. As of September 30, 2012 €3,390,000, or $4,358,000, was outstanding under this term loan facility and $40,642,000 was available for future borrowing. Gentherm Europe is permitted to access this additional term loan financing in one or more draws through no later than January 1, 2013, and the proceeds of such draws may only be used by Gentherm Europe to fund the potential tender of shares of W.E.T. in connection with the DPLTA.

The Company has funded its financial needs from inception primarily through net proceeds received through its initial public offering as well as other equity and debt financing activities. Based on its current operating plan, management believes cash and equivalents at September 30, 2012 along with proceeds from future revenues are sufficient to meet operating needs for the foreseeable future.

### Recent Accounting Pronouncement

*Disclosures about Offsetting Assets and Liabilities.* In December 2011, the FASB issued ASU No. 2011-11 which amends Topic 210 (Balance Sheet). ASU No. 2011-11 is intended to enhance the disclosure requirements for offsetting (netting) assets and liabilities and the effect or potential effect on an entity’s financial position, including the effect or potential effect of rights of setoff associated with certain financial and derivative instruments. The amendments in ASU No. 2011-11 include quantitative disclosure requirements to be presented in tabular format. The tabular disclosure components are as follows:

a) the gross amounts of those recognized assets and those recognized liabilities,

b) the amounts offset in order to determine the net amounts presented in the statement of financial position,

c) the net amounts presented in the statement of financial position,

d) the amounts subject to an enforceable master netting arrangement, if applicable, and

e) the net amount after deducting the amounts in (d) from the amounts in (c).

ASU No. 2011-11 is to be applied retrospectively upon adoption and is effective for annual periods beginning on or after January 1, 2013, and interim periods within those annual periods. While the adoption of ASU No. 2011-11 is not expected to have a material impact on our consolidated condensed financial statements, it could expand our disclosures around certain financial and derivative instruments.

## Market risk

As filed, 11,203 characters.

We are exposed to market risk from changes in foreign currency exchange rates, short term interest rates and price fluctuations of certain material commodities, such as copper. Market risks for changes in interest rates relate primarily to our debt obligations under our Bank of America credit facilities. Foreign currency exchange risks are attributable to sales to foreign customers not denominated in the seller’s functional currency, foreign plant operations, intercompany indebtedness and purchases from foreign suppliers and include exposures to the European Euro, Japanese Yen, Canadian Dollar, Hungarian Forint, Korean Won and Mexican Peso. Our subsidiary W.E.T. regularly enters into derivative contracts with the objective of managing its financial and operational exposure arising from this risk by offsetting gains and losses on the underlying exposures with gains and losses on the financial instruments used to hedge them. While W.E.T. continuously monitors the hedging program, derivative positions and hedging strategies and maintains documentation as to the hedging objectives, practices and procedures, W.E.T. has not typically designated its derivatives as hedging instruments for accounting purposes.

In March 2008, W.E.T. entered into a 10 year currency related interest rate swap (“CRS”) having a notional value of €10,000,000 or $12,854,000 as of September 30, 2012, in order to offset the interest rate risk associated with a debt financing which was repaid prior to our acquisition of W.E.T. Under this agreement W.E.T. receives interest equal to the then six month Euro Interbank Offered Rate (“EURIBOR”), 0.44% at September 30, 2012, plus 1.40% and pays interest equal to the six month EUIBOR when the exchange rate between the European Euro (“EUR”) and the Swiss Franc (“CHF”), which was 1.21 at September 30, 2012, equals or exceeds 1.46 EUR to the CHF or pays interest equal to the six month EURIBOR plus a premium when this exchange rate is less than 1.46. The premium is calculated as \[(1.46 – current EUR/CHF rate)/current EUR/CHF rate\] x 100. W.E.T. has entered into offsetting derivative contracts that cancel out the payment due under the CRS through 2012.

In July 2011, the Company entered into a series of interest rate swap contracts and a interest rate cap agreement designated as cash flow hedges in order to hedge the exposure to variable market interest rates on the Company’s senior debt. Gains and losses reported in accumulated other comprehensive income will be reclassified to earnings once the Company’s senior debt is repaid. Information on the interest rate swap contracts is as follows:

| Contract Type | Contract Term | (in thousands) Notional Value | Hedged Instruments | Fixed Rate | Variable Rate | Rate Cap |
| --- | --- | ---: | --- | ---: | --- | ---: |
| Swap | June 30, 2014 | $8,000 | US Term Note | 1.27% | 3 month LIBOR | — |
| Swap | June 30, 2014 | $8,000 | US Term Note | 1.27% | 3 month LIBOR | — |
| Cap | March 31, 2016 | €14,250 | W.E.T. Term Note | — | 3 month EURIBOR | 2.75 |

The Company uses a market approach to value derivative instruments, analyzing observable benchmark rates at commonly quoted intervals for the instrument’s full term. Information related to the fair values of derivative instruments in our consolidated balance sheet as of September 30, 2012 is as follows:

|  | Hedge Designation | Fair Value Hierarchy | Asset Derivatives Balance Sheet Location | Fair Value | Liability Derivatives Balance Sheet Location | Fair Value | Net Asset/ (Liabilities) |
| --- | --- | --- | --- | ---: | --- | ---: | ---: |
| CRS | Not a hedge | Level 2 |  |  | Current liabilities | $(2,558) |  |
|  |  |  |  |  | Non current liabilities | (13,072) |  |
| Total CRS |  |  |  |  |  | $(15,630) | $(15,630) |
| Foreign currency derivatives | Not a hedge | Level 2 | Current assets | $6 | Current liabilities | $(537) | $(531) |
| Foreign currency derivatives | Cash flow hedge | Level 2 | Current assets | $584 |  |  | $584 |
|  |  |  | Non current assets | 5,082 |  |  | $5,082 |
| Total foreign currency derivatives |  |  |  | $5,672 |  | $(537) | $5,135 |
| Interest rate swap derivatives | Cash flow hedge | Level 2 |  |  | Current liabilities | $(260) | $(260) |

24

Information related to the effect of derivative instruments on our consolidated income statements is as follows (in thousands):

|  | Location | Three Months Ended September 30, 2012 | Nine Months Ended September 30, 2012 |
| --- | --- | ---: | ---: |
| Foreign currency derivatives | Revaluation of derivatives | $(2,036) | $(2,514) |
|  | Foreign currency gain (loss) | 1,051 | 1,722 |
| Total foreign currency derivatives |  | $(985) | $(792) |
| CRS | Revaluation of derivatives | $1,045 | $1,315 |
| Commodity derivatives | Revaluation of derivatives | $(2) | $143 |
| Interest Rate Swap | Interest Expense | $(12) | $(54) |
|  | Other Comprehensive Income | (25) | (55) |

|  | Location | Three Months Ended September 30, 2011 | Nine Months Ended September 30, 2011 |
| --- | --- | ---: | ---: |
| Foreign currency derivatives | Cost of sales | $— | $(15) |
|  | Revaluation of derivatives | (5,621) | (4,326) |
|  | Foreign currency gain (loss) | (2,439) | 2,087 |
| Total foreign currency derivatives |  | $(8,060) | $2,254 |
| CRS | Revaluation of derivatives | $1,745 | $(3,565) |
| Commodity derivatives | Revaluation of derivatives | $(429) | $(293) |
| Series C Convertible Preferred Stock embedded derivatives | Revaluation of derivatives | $— | $2,610 |
| Interest Rate Swap | Cost of sales | $42 | $42 |
|  | Other Comprehensive Income | 283 | 283 |

We did not incur any hedge ineffectiveness during the nine months ended September 30, 2012 and 2011. We recorded an expense of $127,000 from interest payments on interest rate swap agreements designated as hedging instruments within interest expense during the nine months ended September 30, 2012.

#### Interest Rate Sensitivity

The table below provides information about the Company’s derivative financial instruments and other financial instruments that are sensitive to changes in interest rates, including interest rate swaps and debt obligations. For debt obligations, the table presents principal cash flows and related weighted average interest rates by expected maturity dates. For interest rate swaps, the table presents notional amounts and weighted average interest rates by expected (contractual) maturity dates. Notional amounts are used to calculate the contractual payments to be exchanged under the contract. Weighted average variable rates are based on implied forward rates in the yield curve at the reporting date. The information is presented in U.S. dollar equivalents, which is the Company’s reporting currency. The instruments actual cash flows are denominated in both U.S. dollars ($USD) and European Euros (€EUR), as indicated in parentheses.

### September 30, 2012

*(In Thousands except rate information)*

| Liabilities Long Term Debt: | Expected Maturity Date 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | Total | Fair Value |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Fixed Rate (€EUR) | $1,751 | $— | $— | $— | $— | $— | $— | $1,751 | $1,751 |
| Average Interest Rate | 5.50% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 5.50% |  |
| Fixed Rate (¥CNY) | $— | $3,165 | $— | $— | $— | $— | $— | $3,165 | $3,165 |
| Average Interest Rate | 6.90% | 6.90% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 6.90% |  |
| Variable Rate ($USD) | $3,594 | $7,625 | $8,501 | $9,375 | $13,657 | $— | $— | $40,955 | $40,955 |
| Average Interest Rate | 2.86% | 2.86% | 2.86% | 2.86% | 2.86% | 0.00% | 0.00% | 2.86% |  |
| Variable Rate (€EUR) | $1,285 | $5,951 | $4,169 | $780 | $2,226 | $— | $— | $14,411 | $14,411 |
| Average Interest Rate | 2.67% | 2.67% | 2.67% | 2.67% | 2.67% | 0.00% | 0.00% | 2.67% |  |
| Derivative Financial Instruments: |  |  |  |  |  |  |  |  |  |
| Interest Rate Swap ($USD) | $57 | $56 | $17 | $— | $— | $— | $— | $130 | $130 |
| Average Interest Rate | 0.34% | 0.35% | 0.40% | 0.00% | 0.00% | 0.00% | 0.00% | 0.35% |  |
| Interest Rate Swap ($USD) | $37 | $75 | $19 | $— | $— | $— | $— | $131 | $131 |
| Average Interest Rate | 0.34% | 0.35% | 0.39% | 0.00% | 0.00% | 0.00% | 0.00% | 0.35% |  |
| Interest Rate Cap (€EUR) | $— | $— | $— | $— | $6 | $— | $— | $6 | $6 |
| Average Interest Rate | 0.00% | 0.00% | 0.00% | 0.00% | 2.75% | 0.00% | 0.00% | 1.71% |  |

26

#### Exchange Rate Sensitivity

The table below provides information about the Company’s derivative financial instruments, other financial instruments by functional currency and presents such information in U.S. dollar equivalents. The table summarizes information on instruments and transactions and are sensitive to foreign currency exchange rates, including foreign currency forward exchange agreements, €EUR denominated debt obligations and Chinese Yuan (¥ CNY) denominated debt obligations. For debt obligations, the table presents principal cash flows and related weighted average interest rates by expected maturity dates. For foreign currency forward exchange agreements, the table presents the notional amounts and weighted average exchange rates by expected (contractual) maturity dates. These notional amounts generally are used to calculate the contractual payments to be exchanged under the contract.

### September 30, 2012

*(In Thousands except rate information)*

| Anticipated Transactions And Related Derivatives Euro functional currency Forward Exchange Agreements: (Receive USD$/Pay EUR€) | Expected Maturity or Transaction Date 2012 | 2013 | 2014 | 2015 | 2016 | Thereafter | Total | Fair Value |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total Contract Amount(€) | €3,019 | €4,327 |  |  |  |  | €7,346 | €(373) |
| Average Contract Rate | 1.3219 | 1.3867 | — | — | — | — | 1.3609 |  |
| (Receive HUF/Pay EUR€) |  |  |  |  |  |  |  |  |
| Total Contract Amount (€) | €1,520 |  |  |  |  |  | €1,520 | €(50) |
| Average Contract Rate | 296.00 | — | — | — | — | — | 296.00 |  |
| (Receive CHF/Pay EUR) |  |  |  |  |  |  |  |  |
| Total Contract Amount (€) | €— | €12,336 | €12,336 | €12,335 | €12,437 | €18,453 | €67,897 | €4,171 |
| Average Contract Rate | — | 1.20 | 1.20 | 1.20 | 1.20 | 1.20 | 1.20 |  |
| (Receive KRW/Pay EUR€) |  |  |  |  |  |  |  |  |
| Total Contract Amount (€) | €2,424 | €4,536 |  |  |  |  | €6,960 | €(44) |
| Average Contract Rate | 1,454.31 | 1,455.02 | — | — | — | — | 1,454.77 |  |
| **$US functional currency** |  |  |  |  |  |  |  |  |
| **Forward Exchange Agreements:** |  |  |  |  |  |  |  |  |
| (Receive USD$/Pay CAD$) |  |  |  |  |  |  |  |  |
| Total Contract Amount ($) | $1,573 |  |  |  |  |  | $1,573 | $56 |
| Average Contract Rate | 1.0171 | — | — | — | — | — | 1.0171 |  |
| (Receive USD$/Pay JPY¥) |  |  |  |  |  |  |  |  |
| Total Contract Amount ($) | $1,090 |  |  |  |  |  | $2,192 | $64 |
| Average Contract Rate | 82.56 | — | — | — | — | — | 82.56 |  |
| (Receive USD$/Pay MXN) |  |  |  |  |  |  |  |  |
| Total Contract Amount ($) | $2,594 |  |  |  |  |  | $2,594 | $120 |
| Average Contract Rate | 13.5321 | — | — | — | — | — | 13.5321 |  |

27

## Controls and procedures

As filed, 2,743 characters.

### (a) Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2012. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that as of the end of the period covered by our Quarterly Report on Form 10-Q, in light of the material weakness in Internal Control over Financial Reporting described below, our disclosure controls and procedures were not effective to provide reasonable assurance that the information required to be disclosed by us in the reports we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

As disclosed in our Annual Report on Form 10-K, management previously concluded that our internal control over financial reporting was not effective based upon the framework in “Internal Control—Integrated Framework” issued by the Committee of Sponsoring Organizations of the Treadway Commission. Management identified a material weakness in accounting for significant, non-routine transactions. Although there were no such significant, non-routine transactions during the nine month period ended September 30, 2012, we are working to remediate our material weakness in accounting for significant, non-routine transactions by hiring additional highly skilled accountants. Our remediation efforts are likely to be more difficult and costly than they otherwise would be if we were able to register a Domination and Profit and Loss Transfer agreement with our 76% owned subsidiary, W.E.T. Automotive AG. See PART II, ITEM 1., Legal Proceedings, for more information on our efforts to register a Domination and Profit and Loss Transfer agreement.

Notwithstanding the material weakness described above, we have performed additional analyses and other procedures to enable management to conclude that our consolidated financial statements included in this report were prepared in accordance with accounting principles generally accepted in the United States of America.

### (b) Changes in Internal Control over Financial Reporting

During the fiscal quarter ended September 30, 2012, there was no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 146 characters.

There were no material changes in our risk factors previously disclosed in Part I, Item 1A. of our Form 10-K for the year ended December 31, 2011.

Filed Nov 5, 2012.
Source: SEC EDGAR, the filing index for accession 0001193125-12-450815. Last ingested by Listed: Oct 26, 2026, 17:44 ET. No prices; not investment advice.
